Investigation launched into Globus Medical officers for possible self-dealing harming shareholders

Kuehn Law, PLLC is investigating whether certain officers and directors of Globus Medical, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages for shareholders and reforms in corporate governance. Long-term shareholders are encouraged to contact the law firm for a free consultation to protect their rights. The investigation highlights concerns about management integrity and shareholder protection at Globus Medical.

As of Oct 22, 2026 03:41 WIB, Globus Medical Inc. (GMED) trades at USD 78.70 on Pluang, positioned closer to its 52-week low of USD 60.39 than its high of USD 96.82. The stock's market cap stands at $10.60 billion, with a modest 1-day decline of 0.33%. This pricing context highlights the current market valuation relative to its yearly range amid ongoing governance concerns.